OncoArendi Therapeutics SA's total assets for Q1 2026 were zł109.35M, an increase of 15.80% from the previous quarter. PL:MOC total liabilities were zł7.37M for the fiscal quarter, a 5.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.